These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 28032027)

  • 1. Valosin-containing Protein is a Target of 5'-l Fuligocandin B and Enhances TRAIL Resistance in Cancer Cells.
    Arai MA; Taguchi S; Komatsuzaki K; Uchiyama K; Masuda A; Sampei M; Satoh M; Kado S; Ishibashi M
    ChemistryOpen; 2016 Dec; 5(6):574-579. PubMed ID: 28032027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and Evaluation of Fuligocandin B Derivatives with Activity for Overcoming TRAIL Resistance.
    Arai MA; Masuda A; Suganami A; Tamura Y; Ishibashi M
    Chem Pharm Bull (Tokyo); 2018; 66(8):810-817. PubMed ID: 30068801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. VCP inhibitors induce endoplasmic reticulum stress, cause cell cycle arrest, trigger caspase-mediated cell death and synergistically kill ovarian cancer cells in combination with Salubrinal.
    Bastola P; Neums L; Schoenen FJ; Chien J
    Mol Oncol; 2016 Dec; 10(10):1559-1574. PubMed ID: 27729194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Valosin-containing protein VCP/p97 is essential for the intracellular development of Leishmania and its survival under heat stress.
    Guedes Aguiar B; Padmanabhan PK; Dumas C; Papadopoulou B
    Cell Microbiol; 2018 Oct; 20(10):e12867. PubMed ID: 29895095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A small-molecule ligand of valosin-containing protein/p97 inhibits cancer cell-accelerated fibroblast migration.
    Suvarna K; Honda K; Muroi M; Kondoh Y; Osada H; Watanabe N
    J Biol Chem; 2019 Mar; 294(9):2988-2996. PubMed ID: 30610116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyproterone acetate enhances TRAIL-induced androgen-independent prostate cancer cell apoptosis via up-regulation of death receptor 5.
    Chen L; Wolff DW; Xie Y; Lin MF; Tu Y
    BMC Cancer; 2017 Mar; 17(1):179. PubMed ID: 28270124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. UV-induced proteolysis of RNA polymerase II is mediated by VCP/p97 segregase and timely orchestration by Cockayne syndrome B protein.
    He J; Zhu Q; Wani G; Wani AA
    Oncotarget; 2017 Feb; 8(7):11004-11019. PubMed ID: 28036256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decursin enhances TRAIL-induced apoptosis through oxidative stress mediated- endoplasmic reticulum stress signalling in non-small cell lung cancers.
    Kim J; Yun M; Kim EO; Jung DB; Won G; Kim B; Jung JH; Kim SH
    Br J Pharmacol; 2016 Mar; 173(6):1033-44. PubMed ID: 26661339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inclusion body myopathy-associated mutations in p97/VCP impair endoplasmic reticulum-associated degradation.
    Weihl CC; Dalal S; Pestronk A; Hanson PI
    Hum Mol Genet; 2006 Jan; 15(2):189-99. PubMed ID: 16321991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Thioridazine Sensitizes Apoptotic Effect of TRAIL in Human Lung Cancer PC9 Cells Through ER Stress Mediated Up-regulation of DR5].
    Li J; Wang Y; Liu L; Yuan Y; Bao Y
    Zhongguo Fei Ai Za Zhi; 2017 Feb; 20(2):80-87. PubMed ID: 28228218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BRSK2 is a valosin-containing protein (VCP)-interacting protein that affects VCP functioning in endoplasmic reticulum-associated degradation.
    Wang Y; Wan B; Zhou J; Li R; Yu L
    Biotechnol Lett; 2013 Dec; 35(12):1983-9. PubMed ID: 23907667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Silibinin sensitizes TRAIL-mediated apoptosis by upregulating DR5 through ROS-induced endoplasmic reticulum stress-Ca
    Dilshara MG; Jayasooriya RGPT; Molagoda IMN; Jeong JW; Lee S; Park SR; Kim GY; Choi YH
    Oncotarget; 2018 Feb; 9(12):10324-10342. PubMed ID: 29535810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Valosin-containing protein (p97) is a regulator of endoplasmic reticulum stress and of the degradation of N-end rule and ubiquitin-fusion degradation pathway substrates in mammalian cells.
    Wójcik C; Rowicka M; Kudlicki A; Nowis D; McConnell E; Kujawa M; DeMartino GN
    Mol Biol Cell; 2006 Nov; 17(11):4606-18. PubMed ID: 16914519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-6 induced overexpression of valosin-containing protein (VCP)/p97 is associated with androgen-independent prostate cancer (AIPC) progression.
    Duscharla D; Reddy Kami Reddy K; Dasari C; Bhukya S; Ummanni R
    J Cell Physiol; 2018 Oct; 233(10):7148-7164. PubMed ID: 29693262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Verrucarin A sensitizes TRAIL-induced apoptosis via the upregulation of DR5 in an eIF2α/CHOP-dependent manner.
    Moon DO; Asami Y; Long H; Jang JH; Bae EY; Kim BY; Choi YH; Kang CH; Ahn JS; Kim GY
    Toxicol In Vitro; 2013 Feb; 27(1):257-63. PubMed ID: 22982206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-gout agent allopurinol exerts cytotoxicity to human hormone-refractory prostate cancer cells in combination with tumor necrosis factor-related apoptosis-inducing ligand.
    Yasuda T; Yoshida T; Goda AE; Horinaka M; Yano K; Shiraishi T; Wakada M; Mizutani Y; Miki T; Sakai T
    Mol Cancer Res; 2008 Dec; 6(12):1852-60. PubMed ID: 19074830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5, 7-Dimethoxyflavone sensitizes TRAIL-induced apoptosis through DR5 upregulation in hepatocellular carcinoma cells.
    Yang JF; Cao JG; Tian L; Liu F
    Cancer Chemother Pharmacol; 2012 Jan; 69(1):195-206. PubMed ID: 21660448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tanshinone IIA Facilitates TRAIL Sensitization by Up-regulating DR5 through the ROS-JNK-CHOP Signaling Axis in Human Ovarian Carcinoma Cell Lines.
    Chang CC; Kuan CP; Lin JY; Lai JS; Ho TF
    Chem Res Toxicol; 2015 Aug; 28(8):1574-83. PubMed ID: 26203587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oligomycin A enhances apoptotic effect of TRAIL through CHOP-mediated death receptor 5 expression.
    He L; Jang JH; Choi HG; Lee SM; Nan MH; Jeong SJ; Dong Z; Kwon YT; Lee KS; Lee KW; Chung JK; Ahn JS; Kim BY
    Mol Carcinog; 2013 Feb; 52(2):85-93. PubMed ID: 23335397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Baicalein overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance via two different cell-specific pathways in cancer cells but not in normal cells.
    Taniguchi H; Yoshida T; Horinaka M; Yasuda T; Goda AE; Konishi M; Wakada M; Kataoka K; Yoshikawa T; Sakai T
    Cancer Res; 2008 Nov; 68(21):8918-27. PubMed ID: 18974136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.